Vor Biopharma
VOR
VOR
69 hedge funds and large institutions have $140M invested in Vor Biopharma in 2024 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 19 increasing their positions, 20 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
5% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 20
1.81% less ownership
Funds ownership: 88.04% → 86.23% (-1.8%)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
69
Holding in Top 10
1
Calls
$38K
Puts
$1K
Top Buyers
| 1 | +$671K | |
| 2 | +$375K | |
| 3 | +$223K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$181K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$165K |
Top Sellers
| 1 | -$3.19M | |
| 2 | -$515K | |
| 3 | -$87.7K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$71.1K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$59K |